Baillie Gifford & CO Penumbra Inc Transaction History
Baillie Gifford & CO
- $127 Billion
- Q4 2024
A detailed history of Baillie Gifford & CO transactions in Penumbra Inc stock. As of the latest transaction made, Baillie Gifford & CO holds 730,233 shares of PEN stock, worth $195 Million. This represents 0.14% of its overall portfolio holdings.
Number of Shares
730,233
Previous 591,846
23.38%
Holding current value
$195 Million
Previous $115 Million
50.91%
% of portfolio
0.14%
Previous 0.09%
Shares
30 transactions
Others Institutions Holding PEN
# of Institutions
412Shares Held
29.3MCall Options Held
254KPut Options Held
43.3K-
Black Rock Inc. New York, NY4.26MShares$1.14 Billion0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.65MShares$976 Million0.02% of portfolio
-
Champlain Investment Partners, LLC Burlington, VT1.5MShares$400 Million2.36% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD1.27MShares$338 Million0.03% of portfolio
-
State Street Corp Boston, MA1.2MShares$322 Million0.01% of portfolio
About Penumbra Inc
- Ticker PEN
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 37,888,400
- Market Cap $10.1B
- Description
- Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers aspiration based thrombectomy systems and accessory devices, including revascularization device for mechanical thrombectomy, such as Penumbra System under the Penumbra RED, JET, ACE, 3D Revascularization Device...